Factors such as growing prevalence of musculoskeletal disorders and diseases, rapid growth in the geriatric population, rising number of sports-related injuries, and growing adoption of e-commerce platforms for OTC orthopedic braces are driving the growth of the market.
The global OTC braces and supports market is projected to reach USD 1.42 Billion by 2022 from USD 1.10 Billion in 2017, at a CAGR of 5.2%.
OTC braces and supports market into product, application, sales channel, and region. On the basis of product, the market is categorized into lower extremity and upper extremity braces and supports. In 2017, the lower extremity braces and supports segment is expected to account for the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period due to the growing prevalence of obesity & diabetes and the higher prevalence of orthopedic disorders and diseases.
The market is categorized into preventive care, ligament injury, post-operative rehabilitation, osteoarthritis, and other applications (osteoporosis, Paget’s disease, and spinal degenerative conditions). In 2017, the ligament injury segment is expected to account for the largest share of the market, owing to the availability of medical reimbursement for the treatment of ligament injuries and awareness related to the clinical benefits of these products in the effective clinical management of ligament injuries.
As of 2016, major players in the market are DJO Finance LLC (US), Breg, Inc. (US), Ossur Hf (Iceland), DeRoyal Industries, Inc. (US), Bauerfeind AG (Germany), Otto Bock Holding GmbH & Co. KG (Germany), BSN medical (Germany), medi GmbH & Co. KG (Germany), THUASNE Group (France), and 3M Company (US), among others.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly